Mental ill-health during COVID-19 confinement

BMC Psychiatry

Table 1 Prevalence of mental ill health and substance use before and during COVID-19 confinement

	CATALONIA before COVID		CATALONIA during COVID-19 Confinement^a
	n	%	N	%
Depression	3551	7.6% ^c	31,873	22.8%
Anxiety^b	2621	6.7 ^b	32,185	26.9%
Lack of mental well-being	3536	26.2% ^c	37,596	74.8%
Higher risk drinking	1529	8.6% ^d	37,261	9.1%
Smoking	3557	25.6% ^c	37,820	23.0%
Cannabis / hashish (in last 30 days)	2044	11.9% ^d	37,820	3.7%
Prescribed hypnosedatives	2043	5.9% ^d	37,820	17.7%
Non-prescribed hypnosedatives	2044	0.6% ^d	37,820	6.5.%

^aWeighted separately, but sequentially by distributions of gender (male or female), age (16–44, 45–64, and 65+ years), and educational level (primary, secondary, and university or higher) as reported by government statistics of the Catalan population [12]
^bAnxiety was measured by Generalized Anxiety Disorder Scale-7. There is no previous data from Catalonia with this instrument. It is compared with results of the Spanish National Health Survey (2017) [13], using a different instrument which reported a prevalence of 6.7% for chronic anxiety; the same survey found a prevalence of 6.7% for depression in the Spanish population
^cCatalan Health Survey 2018 [15]
^dSpanish Alcohol and Drug Survey 2017 [14], Catalonia only data. For drugs (hypnosedatives and cannabis) the prevalence estimates are based on % of people who reported having taken drugs in the last 30 days. For hypnosedatives with prescription, the data before COVID-19 also includes without prescription

ISSN: 1471-244X